Expression profiles and clinical outcome of cyclin D1− and cyclin D1+ MCL cases was similar, indicating that the hijacking of IGK/IGL enhancers by CCND2 and CCND3 may be a molecular event involved in MCL pathogenesis [244]. This evidence concerns the gene CCND3 and mantle cell lymphoma.